On 7th October, Medigen announced its plans to join forces with Medinet to develop new treatments for cancer patients. Though banned in Asia because of its potential fatal after-effects, Medigen hopes to develop… read more

Expanding on their long-standing macrocyclic peptide discovery alliance between the two companies since 2012, Japan-based PeptiDream announced last week that their proprietary Peptide Discovery Platform System (PDPS) technology will be used to identify… read more

FDA announced the provision of final guidance on "interchangeable" biologics on 10th May 2019, aiming to promote competition in the biologics market. The document will provide clarity for biological product developers on whether… read more

With the acquisition of Bioproduction Group (Bio-G), a leading software provider for biomanufacturing, Emerson now boosts the detection of variability in biological processes by linking real-time data and databases with Bio-G Real-Time Modeling… read more

In partnership with Mesoblast Limited, JCR Pharmaceuticals has filed to extend the marketing approval of TEMCELL®, a mesenchymal stem cell (MSC) wound healing product for patients with Epidermolysis Bullosa (EB). JCR has received… read more

Researchers from Boston Children's Hospital and MIT took mini-antibodies from alpacas Bryson and Sanchez. Then they shrunk the mini-antibodies into even smaller nanobodies and engineered these nanobodies onto CAR-T cells. During this process,… read more

Keytruda® or pembrolizumab, MSD's (Merck in USA/Canada) monotherapy for metastatic small cell lung cancer (SCLC) has been granted accelerated approval by FDA. Keytruda® is now indicated for metastatic SCLC with disease progression on… read more

Biologics: Drugs of the future Consumers are increasingly turning to biological drugs because of its almost pinpoint accuracy in treating specific diseases, making it possible for patients to enjoy safe and effective treatments… read more

The launch of new, temperature sensitive biologics, increasing regulations, growing cost- pressures are putting more complex demands on the biopharma industry’s high-stakes logistics environment.   This growth can be witnessed in part due… read more

The biologics manufacturing industry has undergone several changes over the past few years starting from the development of better expression systems to modular and flexible manufacturing facilities including the emergence and use of… read more